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Abstract 
Hard surfaces submerged in the marine environment often become colonised by macro-
organisms unless the surfaces have some form of biofouling protection. While protective 
paints that contain tributyltin or copper work well to prevent biofouling, release of these 
materials into the environment has been shown to have wider negative impacts. 
Consequently, new low-release antifouling paints are being developed with alternative active 
ingredients, such as avermectins, yet little is known about their potential effects on non-target 
organisms in marine environments. Here we investigated the toxicity of a key avermectin, 
specifically abamectin, on several aspects of reproduction (sperm motility, fertilisation 
success, early larval development) in the Pacific oyster, Crassostrea gigas. Oyster 
reproduction was generally insensitive to the low concentrations of abamectin, although 
greater concentrations of abamectin did negatively affect all three endpoints – LOECs were 
1000 µg.l-1, 500 µg.l-1, and 100 µg.l-1 abamectin for sperm motility, fertilisation success, and 
larval development, respectively. A similar pattern was found in the EC50s of the three 
endpoints (mean ± SE) 934 ± 59 µg.l-1, 1076.26 ± 725.61 µg.l-1, and 140 ± 78 µg.l-1 
abamectin (sperm motility, fertilisation success, and larval development, respectively). 
Together, these results clearly indicate that of the three endpoints considered, larval 
development was more sensitive to abamectin (lower LOEC, EC50) than fertilisation success 
and sperm motility. Although more data are needed from a wider range of marine species and 
environments to fully assess potential toxicity effects on non-target organisms, our results 
highlight the potential utility of abamectin in low-release antifouling paints.  
 
Keywords: avermectin; bioassay; macrocyclic lactones; marine invertebrates; SAAS; 
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1. Introduction 
Untreated exposed surfaces placed in the marine environment are usually quickly colonised 
by a diverse range of marine macro-organisms, which can grow rapidly to create a substantial 
layer of biofouling (Flemming 2002, Chambers et al. 2006, Fitridge et al. 2012). Biofouling 
can have wide-ranging, detrimental, and costly effects: on ships it can reduce speed, increase 
fuel costs, and constrain manoeuvrability; on static structures like platforms and jetties it can 
compromise safety by reducing stability and concealing structural defects; and on aquaculture 
infrastructure biofouling can restrict water exchange, increase disease risk, and cause damage 
to enclosures (Turner 2010, Schultz et al. 2011, Fitridge et al. 2012). Consequently, it is a 
common practice to protect surfaces from biofouling by applying antifouling paints that 
slowly release biocides and prevent the initial settlement of organisms (reviewed in 
Chambers et al. 2006).  
 
While often effective in preventing biofouling, the release of biocides from antifouling 
coatings into the wider marine environment can also have widespread and unintended 
consequences for non-target organisms, ecosystems, and human societies (Terlizzi et al. 
2001). For example, tributyltin (TBT) was a very effective antifouling additive in paints, but 
TBT leakage and contamination adversely affected growth and reproduction in a range of 
non-target organisms including oysters which, in turn, caused large impacts to the associated 
fishing and aquaculture sectors (Alzieu 1991, 2000). As a result, TBT was phased out of 
antifouling coatings (Champ 2003, Gipperth 2009) and replaced by alternative substances 
including copper and zinc (Chambers et al. 2006, Turner 2010). These alternatives also, 
however, have negative effects on non-target organisms, including oysters (Evans et al. 2000, 
Guardiola et al. 2012). Consequently, novel, more environmentally acceptable alternatives 
are being sought (Callow & Callow 2011, Gorman 2014). 
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One group of chemicals gaining attention for their potential use in antifouling coatings are the 
avermectins (e.g. Pinori et al. 2011, Pinori et al. 2013, Trepos et al. 2014), a group of 
macrocyclic lactones that include abamectin, ivermectin, and dormectin (Tišler & Eržen 
2006). Derived from soil microorganisms, these chemicals are often highly toxic to insects 
and can also be toxic to mammals (Fisher & Mrozik 1989, Lankas & Gordon 1989, Wislocki 
et al. 1989). Typically, avermectins have been used as pesticides to control mites, other crop 
pests, and parasites of livestock, as well as in antifilarial chemotherapy in humans (Lumaret 
et al. 2012, Bai & Ogbourne 2016). Of the avermectins, abamectin is potentially the most 
suitable candidate for incorporation in antifouling paints from a regulatory standpoint; 
abamectin has already been approved and registered in the Biocide Products Regulation 
(European Chemicals Agency) under PT18 (as an insecticide in agricultural/for terrestrial 
use), and therefore many of the requirements for registration under PT21 (antifouling 
purposes) have been complied with (EuropeanCommission 2011). There remains, however, a 
lack of understanding regarding effects of abamectin specific to aquatic systems, which must 
be addressed before abamectin can be approved for use in commercial antifouling products. 
 
To date, most focus on the impacts of avermectins in aquatic systems relates to the toxicity of 
run-off from terrestrial pesticide use into freshwater habitats (see Lumaret et al. 2012 for a 
comprehensive summary of the ecotoxicity of macrocylic lactones). Relatively little is known 
about the toxicity of abamectin released into the marine environment, and there are few 
ecotoxicological assessments involving marine or estuarine organisms (Table 1). Only two 
studies tested the effects of abamectin on sensitive early life history stages of reproduction 
(Tamparon et al. 2015) or larval development (Wislocki et al. 1989) (results reported in 
Table 1). Broadcast spawning organisms are of particular interest in this context as their 
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external reproduction may make them particularly sensitive to antifoulants (Gazeau et al. 
2013). For example, reproduction in the Pacific oyster, Crassostrea gigas, which releases 
gametes freely to the water column where external fertilisation and subsequent larval 
development take place (Yonge 1960, Park et al. 1988), has been shown to be affected by 
biocides (e.g. Alzieu 1991, Alzieu 2000). Moreover, species that reside in shallow coastal 
areas may experience particularly high concentrations of biocides (Thomas 2001). Thus there 
is a clear need for more information on toxicity of abamectin to broadcast-spawning species 
inhabiting shallow coastal marine environments where biocide concentrations from 
antifouling coatings are likely to be greatest. We chose to address these issues in the 
common, invasive, and free-spawning bivalve C. gigas. Investigating the impacts of 
abamectin on C. gigas is of particular value given the diverse, and valuable, ecosystem 
services provided by this species (Grabowski et al. 2012, Lemasson et al. 2017). 
Consequently, here we investigated the effects of abamectin on multiple reproductive 
endpoints (sperm motility, fertilisation success, early larval development) in the Pacific 
oyster, Crassostrea gigas.  
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Table 1. Ecotoxicological data available for abamectin exposure in marine and estuarine 
species  
 
Species 
Common 
name 
Phylum Duration, method, LC/EC50 Reference 
Panaeus duorarum Pink shrimp Crustacea 96 h exposure of adults: LC50 = 1.6 µg.l
-1 Wislocki et al. (1989) 
Americamysis bahia 
Mysid 
(estuarine) 
Crustacea 96 h exposure of adults: LC50 = 0.022 µg.l
-1 Wislocki et al. (1989) 
Callinectes sapidus Blue crab Crustacea 96 h exposure of adults: LC50= 153 µg.l
-1 Wislocki et al. (1989) 
Strongylocentrotus sp. Sea urchin Echinodermata 
10 h exposure of fertilising eggs/developing 
larvae: LC50 = ~ 1 µg.l
-1 
Tamparon et al. (2015) 
Crassostrea virginica 
Eastern 
oyster 
Mollusca 
96 h exposure of fertilising eggs/developing 
larvae: LC50 = 430 µg.l
-1 
Wislocki et al. (1989) 
Crassostrea gigas 
Pacific 
oyster 
Mollusca 
20 min exposure sperm motility:               
EC50 = 1017 µg.l
-1 
This study 
Crassostrea gigas 
Pacific 
oyster 
Mollusca 
2 h exposure of fertilising eggs:               
EC50 = 4202 µg.l
-1 
This study 
Crassostrea gigas 
Pacific 
oyster 
Mollusca 
26 h exposure of developing larvae:         
EC50 = 72 µg.l
-1 
This study 
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2. Materials and Methods 
2.1 Collection of animals and gametes  
Adult Pacific oysters, Crassostrea gigas, were collected from Tjärnö, Sweden in December 
of 2014 and transferred to Ostrea Svergie AB (Koster, Sweden) where they were conditioned 
to maturity under laboratory conditions. Experiments were conducted at the Sven Lovén 
Centre for Marine Sciences (Tjärnö, Sweden) in July of 2015. All experiments were run at 20 
± 1°C (the typical ambient seawater temperature in this region during the spawning season). 
 
Concentrated gametes were extracted from each individual using a Pasteur pipette inserted 
through a hole drilled in the shell above the gonad (Havenhand & Schlegel 2009). Sperm 
from each male were stored in separate Eppendorf tubes on ice to maximise longevity, eggs 
from each female were stored separately in 0.22 µm filtered seawater (FSW) at ambient 
temperature. For each male, sperm concentrations were determined from hemocytometer 
counts of samples stained and immobilised with Lugol’s solution. Sperm from three males 
were then pooled to obtain a concentrated mixed batch with equal (1:1:1) representation from 
each male. Extracted eggs were left in FSW for one hour to allow their hydration, during 
which time concentrations were adjusted such that eggs of three females could be combined 
to form a pooled batch with equal (1:1:1) representation. Gametes were pooled to reduce 
subsequent variation in response variables caused by individual differences in male:female 
compatibility. These pooled batches of gametes were used for all experiments. 
 
2.2 Experimental treatment: abamectin addition 
Abamectin (CAS 71751-41-2) is a mixture of ≥ 80% avermectin B1a (C47H70O14 CAS 65195-
55-3) and ≤ 20% avermectin B1b (C48H72O14 CAS 65195-56-4). Experimental treatments 
were prepared by diluting an abamectin stock solution (Wuhan Yuancheng Technology 
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Development Co., China) with FSW to yield five effective final abamectin concentrations 
(1000, 500, 100, 10 and 1 µg.l-1), plus a FSW control (0 µg.l-1).  
 
2.3 Sperm motility, fertilisation success, larval development 
Sperm motility was quantified using the Sperm Accumulated Against Surface (SAAS) 
technique (Falkenberg et al. 2016). Sperm were diluted with seawater containing the 
appropriate abamectin treatment (0, 1, 10, 100, 500, or 1000 µg.l-1) to a concentration of 2 × 
106 sperm.ml-1 in each of six replicate wells in a multi-well plate. Sperm suspensions were 
left for 10 min before pipetting 1.5 ml into new wells. The bottom surface of each new well 
was then observed using a phase-contrast inverted microscope (Leica, DMIL, Germany) 
equipped with a digital video camera (PixeLINK, PL-D725CU, Canada). Sperm 
accumulation after a further 10 min (i.e. 20 min after initial exposure to the treatments) was 
determined by counts from still images of different central areas of the lower surface of the 
wells (n = 3 images per well). This procedure was repeated for “dead” sperm diluted with 
FSW (0 µg.l-1; sperm were killed by warming  to ~50 °C for 5 min, after which time no 
motile sperm were observed).  
 
Fertilisation success was quantified using eggs mixed with the same sperm as used in sperm 
motility trials. Final concentrations of gametes were adjusted to yield 5 × 108 sperm.ml-1 and 
300 eggs.ml-1 in the treatments (previous work had shown that these concentrations resulted 
in ~50% fertilisation success in controls, which maximises sensitivity of the assay and allows 
for positive responses to the treatments; Marshall 2006). Gametes were mixed with seawater 
containing the appropriate abamectin treatment (0, 1, 10, 100, 500, or 1000 µg.l-1) and left to 
fertilise for 12 min. Fertilisations were then halted by separating sperm and eggs via 
centrifugation for 5 min at 2000 g (Eppendorf, Centrifuge 5810R, Germany). The supernatant 
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containing the sperm was discarded and the remaining 1 ml of lightly pelleted eggs were 
resuspended in 6.5 ml of the appropriate treatment water, 2.5 ml of which was distributed to 
each of three 35 mm Petri dishes. Each dish was photographed (Nikon D810, Japan, DSLR 
camera mounted on an Olympus SZX16, Japan microscope) and total egg count determined 
using the ‘Colony Counter’ plugin in ImageJ64 (Schneider et al. 2012). Eggs were left to 
develop for 2 h after fertilisation, after which time each replicate dish was photographed 
again. Fertilisation success was determined by recording the proportion of cleaving eggs in 
each of the three replicate dishes.  
 
To quantify larval development, eggs/embryos used in fertilisation trials were maintained in 
their treatments until 26 h post-fertilisation (the point at which larvae of this species reach the 
D-stage; Park et al. 1988), after which they were euthanised with 95 % ethanol to stop 
development. The total number of D-stage larvae in each well was subsequently counted 
manually under a microscope (Olympus IX71) and compared to the total egg count obtained 
earlier to provide larval development success. 
 
2.4 Statistical analysis 
Each response variable (i.e. sperm motility, fertilisation success, and larval development) was 
analysed with a separate one-way ANOVA with ‘abamectin concentration’ as a fixed factor 
(6 levels) and n = 6 replicate wells for sperm motility or n = 3 dishes for fertilisation success 
and larval development. Prior to analysis, sperm motility data were square root transformed, 
fertilisation success and larval development data were arc-sine transformed, and model 
estimates/residuals inspected visually to ensure normality (following Quinn & Keough 2002, 
Zuur et al. 2010). When relevant, post-hoc Tukey's tests were used to identify which 
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treatment levels of abamectin concentration differed. Analyses were done in SPSS V.24 
(IBMCorp 2016). 
 
The resulting data were modelled using the R package DRC to produce dose-response curves 
and calculate toxicity estimates (Figure A1) (Ritz & Streibig 2005). Regression models tested 
included log-logistic and Weibull models with different levels of parameterization. For sperm 
motility models, a lower limit was set at 15 as this was the average sperm accumulated at 
surface (SAAS) in the dead controls. Akaike’s Information Criterion (AIC) was used to 
compare models. The concentrations of abamectin that produced a 50% inhibition between 
the maximal and baseline in each of the specified endpoints (EC50) were determined from the 
best-fit models. Confidence limits (95%) were estimated using the delta method. For larval 
development, the EC50 was lower than the LOEC and therefore we used the same fitted dose-
response model to also calculate an EC10 (the concentration of abamectin that produced a 
10% inhibition) as this provides a more reliable measure of a concentration where small 
biological effects were predicted (Warne & van Dam 2008). 
 
3. Results 
All three measures of oyster reproduction showed a statistically significant, negative dose-
dependent response to abamectin (Figure 1; sperm motility: F(5, 12) = 5.787, p = 0.001; 
fertilisation success: F(5, 12) = 12.513, p < 0.001; larval development: F(5, 12) = 25.011, 
p < 0.001). The sensitivity of this dose-response increased with developmental stage 
(Figure 1) such that sperm motility was significantly reduced (relative to controls) only at the 
greatest concentration of abamectin (Figure 1A, 1000 µg.l-1; post-hoc tests), whereas 
fertilisation success was significantly reduced at the two greatest abamectin concentrations 
(Figure 1B; 500, 1000 µg.l-1; post-hoc tests), and larval development was significantly 
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reduced relative to controls at the three greatest abamectin concentrations (Figure 1C; 
reduced at 100 µg.l-1, and completely inhibited at 500 and 1000 µg.l-1; post-hoc tests). 
Consequently, the Lowest Observable Effect Concentrations (LOECs) were 1000 µg.l-1, 
500 µg.l-1 , and 100 µg.l-1 for sperm motility, fertilisation success, and larval development 
respectively.  
 
Dose-response curves produced EC50 estimates for both sperm motility and fertilisation 
success that were close to the greatest abamectin concentration tested (i.e. ~ 1000 µg.l-1), 
whereas the EC50 estimate for larval development was much lower and well within the range 
of concentrations tested (i.e. < 1000 µg.l-1). For sperm motility, the best fit dose response 
model was a Weibull (type 1) four parameter model (Table A1), EC50 (mean ± SE) = 934 ±  
59 µg.l-1. For fertilisation success the best fit model was a Weibull (type 2) three parameter 
model (Table A1), EC50 = 1076.26 ± 725.61 µg.l
-1. In contrast, the fitted larval development 
EC50 estimate was much lower (and within the range of abamectin concentrations tested); the 
best fit model was a Weibull (type 1) three parameter model (Table A1), EC50 = 140 ± 
78 µg.l-1. Because the EC50 was similar to the LOEC for this endpoint, we used the same 
fitted dose-response model to calculate an EC10 which was 24 ± 52 µg.l
-1.  
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Figure 1. Response of oyster, Crassostrea gigas, sperm motility (A), fertilisation success (B), and 
larval development (C) to abamectin. Data points are means ± SE (n = 6 for sperm motility, n = 3 for 
fertilisation and larval development); letters represent groups that were significantly different in post-
hoc tests; dashed line in (A) represents sperm accumulation after 20 min for a dead sperm (control) 
treatment in seawater.  
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4. Discussion 
We found that sperm motility, fertilisation success, and early larval development in the 
Pacific oyster were relatively robust to short-term exposure to abamectin. This robustness 
did, however, vary among the response variables. That is, sensitivity to abamectin increased 
with developmental stage and exposure time (i.e. sperm motility and fertilisation success 
were less sensitive than larval development). This finding was reflected both in the lowest 
concentrations at which significantly reduced responses were detected (i.e. LOEC) and 
estimated concentrations that would produce 50% inhibition between maximal and baseline 
measures (i.e. EC50). Similar patterns of increasing sensitivity in sequential developmental 
stages (e.g. sperm motility < fertilisation success < larval development) have been identified 
for a range of organisms with other additives (e.g. Ringwood 1992, Bellas et al. 2001, 
Geffard et al. 2001, Fitzpatrick et al. 2008). Such effects are perhaps unsurprising given the 
dependence of higher developmental stages on lower ones. While sperm motility would only 
be affected by direct effects on this stage, fertilisation success would be influenced by any 
direct effect on this process and the effect on sperm motility, while larval development would 
be determined by direct effects on this process, fertilisation success and sperm motility 
(Fitzpatrick et al. 2008). Moreover, later developmental stages were exposed to the 
treatments for longer periods, creating the possibility for expression of more chronic 
responses. Consequently, despite the potential for all the reproductive endpoints considered 
here to be used as ecotoxicological endpoints (e.g. Lewis & Watson 2012, Falkenberg et al. 
2016), larval development may be the most sensitive.  
 
Our results are broadly comparable to the responses of other aquatic organisms to 
avermectins (responses to abamectins summarised in Table 1). In terms of larval 
development, the EC50 we observed here (140 ± 78 µg.l
-1) was lower than – but within an 
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order of magnitude of – that reported in Wislocki et al. (1989) for fertilising/early developing 
larvae in the eastern oyster, Crassostrea virginica (LC50: 430 µg.l
-1). It is important to note, 
however, that the Wislocki et al. (1989) test involved 96 h continuous exposure to elevated 
abamectin concentrations, whereas our exposure time for the larval development test was 
26 h. Clearly such differences in exposure time preclude direct comparisons of sensitivity of 
larval development to abamectin (Wislocki et al. 1989 also report few details of their tests, 
which further precludes relevant comparison). It does appear, however, that other organisms 
exposed to abamectin for long periods (96 h) were much more sensitive to abamectin than 
oysters (e.g. mysid, Americamysis bahia, LC50 = 0.022µg.l
-1; Table 1). Similar differences in 
sensitivity are also apparent for shorter exposure times: the only short duration (10 h) test of 
abamectin on a marine invertebrate (fertilisation/larval development in the sea urchin, 
Strongylocentrotus sp., LC50 = ~ 1 µg.l
-1; Tamparon et al., 2015) identified greater sensitivity 
than we detected for oysters (2 h exposure of fertilising eggs EC50 = 4202 µg.l
-1, 26 h 
exposure of developing larvae EC50 = 72 µg.l
-1; Table 1). In freshwater species, sensitivity to 
abamectin can be even more variable, with EC50 ranging over six orders of magnitude (from 
4000 µg.l-1 for the rotifer Brachionus caclcyflorus, to 0.0051 µg.l-1 for the cladoceran 
Daphnia similis; summarised in Casali-Pereira et al. 2015). If comparisons are extended to 
another avermectin, specifically ivermectin, similar results and variability in sensitivity are 
also found (summarised in Davies et al. 1997, Lumaret et al. 2012, Bai & Ogbourne 2016). 
Together, these results clearly indicate that more data are required before the toxicity of 
abamectin can be generalised for aquatic species. 
 
Comparisons of assessments for sensitivity to a biocide need to consider not only the 
endpoint and species tested, but also the likely relevance of exposure duration and 
concentration to those found in the field. The only previous assessment of oyster responses to 
15 
 
 
abamectin involved static tests over relatively long periods of time (96 h; Wislocki et al 
1989). We purposefully chose to run much shorter exposures (≤ 26 hrs) that corresponded to 
clear developmental end-points (second cleavage is visible 2 h after fertilisation and larvae 
reach D-stage 15-28 h after fertilisation; Park et al. 1988). In terms of concentration, 
available data confirm that concentrations of abamectin in seawater near treated surfaces are 
likely to be much lower than the LOECs and EC50s we observed. For example, Pinori et al. 
(2013) measured a steady-state release rate for a formulation containing ivermectin (0.1% 
w/v) at 34 – 70 ng.cm-2.d-1. Assuming similar formulations and release rates for abamectin, 
this would suggest that concentrations high enough to have biological effects may only 
accumulate in very small volumes of water in boundary layers immediately adjacent to 
painted surfaces. However, in small or isolated bodies of water with many coated surfaces 
(e.g. a marina) the concentrations of abamectin to which sperm/eggs/developing larvae are 
exposed might be greater, or, as with other avermectins, the biocide might accumulate and 
persist in the sediment. In the latter case, organisms may be affected over longer time periods 
and effects (both lethal and sub-lethal) on adult/benthic life stages would also be relevant 
endpoints (Davies et al. 1997, Grant & Briggs 1998, Sanderson et al. 2007).  
 
In the marine environment more generally, background concentrations of avermectins are 
likely to be much lower than those that had an effect here. Non-antifouling sources of 
avermectins in the marine environment can include run-off from agricultural spraying, direct 
pharmaceutical use in aquaculture and, rarely, spillage of concentrated products during 
transport (Tišler & Eržen 2006, Bai & Ogbourne 2016). While these sources may drive local 
elevations in avermectin concentration over brief periods, it has been argued that the 
concentrations of these chemicals are likely to be low in marine waters as they generally bind 
readily to soils and sediments and have short half-lives in aquatic environments (Wislocki et 
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al. 1989, Sanderson et al. 2007). It should be noted, however, that concentrations and 
toxicities of avermectins (and their breakdown products) in aquatic settings are poorly known 
(Bai & Ogbourne 2016). Nonetheless, it seems likely that the additional risk from abamectin-
based antifouling paints to reproduction in oysters is negligible. 
 
Increasingly, there is a need to study and understand the potential effects of alternatives to 
traditional antifouling substances – in this case abamectin. Here, we identified that although 
acute exposure of oyster sperm and eggs impaired sperm motility, fertilisation success, and 
larval development, these responses were only observed at high concentrations of abamectin. 
While our results are an indication that abamectin use in low-release antifouling paints is 
unlikely to have unintended environmental consequences for early life-stages of Pacific 
oysters, more work is needed to draw a general conclusion. Of particular priority for 
consideration should be the large variation found in sensitivity among different species and 
life stages (noted above) and whether a sufficient diversity of species has been tested to 
characterise the general toxicity of abamectin in the marine environment. In addition, 
environmentally relevant exposure times should be considered; for example, longer-term 
chronic exposure of adults to abamectin may be relevant if this substance accumulates in 
benthic sediments, potentially resulting in sub-lethal effects that modify reproductive stages 
(as observed in terrestrial studies Elbetieha & Da’as 2003, Celik-Ozenci et al. 2011, Celik‐
Ozenci et al. 2012). When combined with the understanding gained from future studies 
addressing these issues, our findings might then better inform decision-making regarding the 
use of abamectin in marine antifouling products, enabling the prevention of biofouling while 
also limiting unintended impacts in the marine environment. 
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Appendix 
 
Table A1. Dose-response models fitted to the data for oyster, Crassostrea gigas, sperm 
motility, fertilisation success, and larval development to abamecin. Best-fit models (bold) 
were selected using the Akaike Information Criterion (AIC). Lack-of-fit test results and 
model parameter estimates are provided for each model 
 
 
Sperm motility Fertilisation success Larval development 
Model AIC     
3 Parameter Log-Logistic  - 147.8919 77.69906 
4 Parameter Log-Logistic  991.6713 148.3451 77.69906 
5 Parameter Log-Logistic  993.6888 150.3454 79.33248 
3 Parameter Weibull type I - 148.0950 77.14799 
4 Parameter Weibull type I 991.6466 148.3421 77.59704 
3 Parameter Weibull type II - 147.3710 83.03142 
4 Parameter Weibull type II 1056.6576 148.3422 79.72869 
Lack of Fit test results       
 F(102,105) = 0.6816, p = 0.5653 F(12,15) = 0.9341, p = 0.4543 F(12,15) = 3.2529, p = 0.0598 
Model Parameters (estimate [SE], significance)     
Hillslope 2.72 [0.92], p = 0.004 -0.69 [0.43], p = 0.125 1.07 [1.03], p = 0.311 
Lower limit fixed at 15 fixed at 0 fixed at 0 
Upper Limit 104.51 [2.79], p = ≤0.001 42.97 [3.83], p = ≤0.001 8.71 [0.97], p = ≤0.001 
Inflection Point 1069.04 [76.67], p = ≤0.001 633.81 [338.11], p = 0.081 196.82 [67.09], p =0.01 
Asymmetry factor NA NA NA 
Residual SE 23.31 (df = 105) 12.72 (df = 15) 1.81 (df = 15) 
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Figure A1. Best fit dose-response models (Table A1) of oyster, Crassostrea gigas, sperm motility 
(A), fertilisation success (B), and larval development (C) to abamectin. Data points are means ± SE 
(n = 6 for sperm motility, n = 3 for fertilisation and larval development); the solid grey line is the 
modelled dose response curve used to derive EC50 and EC10; the shaded region represents the 95% 
confidence limits provided by the model 
 
